^
Association details:
Biomarker:No biomarker
Cancer:Cutaneous Melanoma
Regimen:CaT (carboplatin + paclitaxel)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
02/19/2021
Excerpt:
Melanoma: Cutaneous...Considerations for cytotoxic agents…Among the recommended cytotoxic options, combination of carboplatin and paclitaxel or single-agent temozolomide are preferred.